Skip to main content
. 2014 Nov 20;16(1):217–221. doi: 10.1208/s12249-014-0241-5

Fig. 3.

Fig. 3

Observed (obs.) and predicted (pre.) dissolution profiles for montelukast sodium using fasted state simulated intestinal fluid (FaSSIF) using USP apparatus II at 37°C in the following condition: 500 mL at 75 rpm, 500 mL at 100 rpm, and 900 mL at 75 rpm